Seelos Therapeutics (NASDAQ:SEEL) stock observed trading -35.41% off 52-week high price. On the other end, the stock has been noted 221.81% away from low price over the last 52-weeks. The stock disclosed a move of 24.92% away from 50 day moving average and 45.06% away from 200 day moving average. Moving closer, we can see that shares have been trading -5.54% off 20-day moving average. It has market cap of $70.75M.
On Jan. 6, 2021, Seelos Therapeutics (NASDAQ:SEEL) a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, declared its year end 2020 business update.
This past year marked the most significant 12 months in Seelos Therapeutics’ history despite being an otherwise challenging year due to the COVID-19 pandemic. We completed our safety trial for the intranasal ketamine program and began opening centers for our pivotal trial for Acute Suicidal Ideation and Behavior in patients with major depressive disorder. The trehalose program’s pivotal study in ALS was accepted into the HEALEY ALS Platform Trial at Harvard and we began our first in vivo studies of SLS-004 and SLS-007, our gene therapy Parkinson’s programs. Seelos received additional patents around the world, orphan drug designations in the US and Europe for various programs plus a Rare Pediatric Disease Designation for SLS-005, remarked Raj Mehra Ph.D., Chairman and CEO of Seelos. We look forward to 2021 as we embark on clinical studies in two unmet needs, namely imminent suicidality and ALS. We have expanded the Seelos team by adding several experienced industry veterans as full-time Seelos employees to efficiently execute clinical and preclinical programs.
The USA based company Seelos Therapeutics moved with change of -4.93% to $1.35 with the total traded volume of 1131214 shares in recent session versus to an average volume of 1.34M. The stock was observed in the 5 days activity at -7.53%. The one month performance of stock was 33.66%. SEEL’s shares are at 52.20% for the quarter and driving a -4.26% return over the course of the past year and is now at -14.56% since this point in 2018. Right now the stock beta is 2.34. The average volatility for the week and month was at 11.87% and 15.78% respectively. There are 46.99M shares outstanding and 46.28M shares are floated in market.